INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the third quarter of 2025 and provided an update on recent company developments.
What's Your Reaction?











